Safety and efficacy of cabozantinib for metastatic nonclear renal cell carcinoma: Real-world data from an Italian managed access program

M. Prisciandaro, R. Ratta, F. Massari, G. Fornarini, S. Caponnetto, R. Iacovelli, U. De Giorgi, G. Facchini, S. Scagliarini, R. Sabbatini, C. Caserta, G. Peverelli, A. Mennitto, E. Verzoni, G. Procopio

Research output: Contribution to journalArticlepeer-review

Cite this